Tamara Fedorovna Solov'Eva

Tamara Fedorovna Solov'Eva

Auto-generated profile, based on publicly available information

Tamara Fedorovna Solov'Eva


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
SBSvetlana Bakholdina
Svetlana Bakholdina
TSTamara Fedorovna Solov'Eva
Tamara Fedorovna Solov'Eva
GNGennadii Aleksandrovic Naberezhnii
Gennadii Aleksandrovic Naberezhnii
Sepsis is a life-threatening complication of an infectious process that results from excessive and uncontrolled activation of the host's pro-inflammatory immune response to a pathogen. Lipopolysaccharide (LPS), also known as endotoxin, which is a major component of the Gram-negative bacteria outer membrane, plays a key role in the development of Gram-negative sepsis and septic shock in humans. To date, no specific and effective drug against sepsis has been developed. This review summarizes data on LPS-binding proteins from marine invertebrates (ILBPs), that inhibit LPS toxic effects, and are of interest as potential drugs for the sepsis treatment. The structure, physicochemical properties, antimicrobial and LPS-binding/neutralizing activity of these proteins and their synthetic analogues are considered in details. Problems that arise during clinical trials of potential anti-endotoxic drugs are discussed.